Dr. Clevenger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1101 E. Marshall St
Sanger 4-006A
Richmond, VA 23298Phone+1 804-828-0183Fax+1 804-828-9749
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1987 - 1991
Northwestern University The Feinberg School of MedicineClass of 1987- University of Pennsylvania Health SystemFellowship, Cytopathology
Certifications & Licensure
VA State Medical License 2013 - 2024
IL State Medical License 2004 - 2014
PA State Medical License 1989 - 2006- American Board of Pathology Anatomic Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Elected Member The American Society for Clinical Investigation, 2003
Clinical Trials
- Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer Start of enrollment: 2001 Aug 01
Publications & Presentations
PubMed
- 90 citationsVav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line.Charles V. Clevenger, Winnie Ngo, Deborah L. Sokol, Selina M. Luger, Alan M. Gewirtz
The Journal of Biological Chemistry. 1995-06-02 - 68 citationsRequirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes.Charles V. Clevenger, Amy L. Sillman, Joan Hanley-Hyde, Michael B. Prystowsky
Endocrinology. 1992-06-01 - 125 citationsRequirement of nuclear prolactin for interleukin-2--stimulated proliferation of T lymphocytes.Charles V. Clevenger, Scott W. Altmann, Michael B. Prystowsky
Science. 1991-07-05
Journal Articles
- Circulating Prolactin Concentrations and Risk of Type 2 Diabetes in US WomenCharles Clevenger, MD, Diabetologia
- Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary GlandCharles Clevenger, MD, Clinical Cancer Research
Press Mentions
Potential Treatment of Breast Cancer Through Targeted Drugs, Reveals New StudyMay 2nd, 2021- Breakthrough Study Uncovers Potential Treatment of Breast Cancer Through Targeted DrugsApril 27th, 2021
VCU Researchers Studying Protein Involved in Milk Production to Treat Breast CancerMay 6th, 2019- Join now to see all
Grant Support
- Multimeric Signaling Complexes In PRLR TransductionNational Cancer Institute2011–2012
- Multimeric Signaling Complexes In PRLR TransductionNational Cancer Institute2005–2010
- Regulation Of STAT Function In Breast CancerNational Cancer Institute2005–2007
- Function Of The PRL Receptor Complex In Breast CancerNational Cancer Institute2006
- Function Of The PRL Receptor Complex In Breast CancerNational Cancer Institute2002–2005
- Regulation Of STAT Function In Breast CancerNational Cancer Institute2003–2004
- Multimeric Signaling Complexes In PRLR TransductionNational Cancer Institute2001–2004
- Prolactin Receptor Complex In Breast CancerNational Cancer Institute1999–2001
- Mechanisms Of Prolactin Receptor Signaling By VAVNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Autocrine Function Of Prolactin In Breast CancerNational Cancer Institute1996–1998
- Prolactin Receptor Function In T-LymphocytesNational Institute Of Allergy And Infectious Diseases1993–1997
- Regulation Of T-Lymphocyte Proliferation By ProlactinNational Institute Of General Medical Sciences1990–1991
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
